Skip to main content
OpenTrials
Completed

NCT Number: NCT04581577

Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With NMD

This study aims to evaluate perceived clinical and psychosocial experiences of patients and their families during the Covid-19 pandemic. it is important to understand the implications of the pandemic for this population, particularly given its likely protracted course, and resultant limitations to daily activities and clinical care. This will help clinicians plan support and adaptations to the services they provide in the medium to long term.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromuscular Diseases Nervous System Diseases Neurological Diseases or Conditions

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Brompton Hospital

London, SW3 6HP, United Kingdom

About this study

As above

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult group

  • Patient over 16 years of age with a confirmed diagnosis of neuromuscular and/or neurological disorder
  • Able and willing to provide informed consent

Paediatric group

  • Parent of a patient under 16 years of age with a confirmed diagnosis of neuromuscular and/or neurological disorder
  • Able and willing to provide informed consent

Exclusion criteria

  • Unwilling for telephone questionnaire to be audio-recorded

Treatment and study plan

Semi-structured telephone questionnaire

Other

Semi-structured telephone questionnaire

Primary outcomes

  1. Qualitative evaluation of the perceived clinical and psychosocial impact of the Covid-19 pandemic in patients with neuromuscular and neurological disorders

    Time frame: 4 months

    Evaluation of semi-structured questionnaires using thematic analysis

Secondary outcomes

  1. Quantification of the proportion of patients with NMD who have had suspected or confirmed Covid-19 infection during the pandemic

    Time frame: 4 months

    Quantitative analysis of the proportion of questionnaire respondents reporting confirmed or suspected Covid-19 infection

  2. Qualitative evaluation of the social environment of patients with NMDs

    Time frame: 4 months

    Qualitative analysis describing the social environment of patients with NMDs

  3. Qualitative evaluation of the social activities of patients with NMDs

    Time frame: 4 months

    Qualitative analysis describing the social activities of patients with NMDs

  4. Qualitative evaluation of the professional activities of patients with NMDs

    Time frame: 4 months

    Qualitative analysis describing the professional activities of patients with NMDs

  5. Qualitative evaluation of the impact of the Covid-19 pandemic on families of patients with neuromuscular and neurological disorders

    Time frame: 4 months

    Evaluation of semi-structured questionnaires using thematic analysis

  6. Qualitative evaluation of concerns regarding medical care from the perspective of patients with NMDs and their families during the Covid-19 pandemic

    Time frame: 4 months

    Evaluation of semi-structured questionnaires using thematic analysis

Sponsors and collaborators

Lead sponsor

Royal Brompton & Harefield NHS Foundation Trust

Other

Registry information

Official study title

Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders

Acronym: CLASSIC

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Oct 9, 2020
Registry last updated
Oct 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.